Literature DB >> 30151700

Long noncoding RNA MALAT1 acts as a competing endogenous RNA to regulate Amadori-glycated albumin-induced MCP-1 expression in retinal microglia by a microRNA-124-dependent mechanism.

Ning Dong1, Bing Xu2, Hong Shi2.   

Abstract

OBJECTIVE: To determine whether the long noncoding RNA MALAT1 may be involved in the inflammatory effect of Amadori-glycated albumin (AGA) in retinal microglia via a microRNA-124 (miR-124)-dependent mechanism.
METHODS: Diabetes mellitus was induced by streptozotocin (STZ) injection. The expression of monocyte chemotactic protein-1 (MCP-1) in the retinas of rats was determined using quantitative reverse transcription-PCR (qRT-PCR) analyses and enzyme-linked immunosorbent assay (ELISA). Both qRT-PCR and ELISA were used to detect the levels of MCP-1 mRNA and soluble MCP-1 protein in the primary rat retinal microglia treated with AGA. The regulation of a putative target of miR-124 was validated by luciferase reporter assays.
RESULTS: MALAT1 knockdown ameliorated diabetic retinopathy (DR) and inhibited MCP-1 release in the retinas of STZ-induced diabetic rats. The cultured retinal microglial cells treated with AGA-released MCP-1 in a dose- and time-dependent manner. In addition, AGA consistently induced MALAT1 expression in the retinal microglial cells. Next, we demonstrated that the expression of MCP-1 is controlled by miR-124, which binds to the 3'-UTR of MCP-1 in microglial cells. Luciferase reporter assays and RNA-binding protein immunoprecipitation assays showed that MALAT1 targets miR-124. Finally, we demonstrated that MALAT1 acts as a competing endogenous RNA by directly binding to miR-124 to regulate AGA-induced MCP-1 expression in microglial cells.
CONCLUSIONS: MALAT1-miR-124-MCP-1 signaling pathway may be involved in AGA-induced MCP-1 expression in microglial cells, which may provide a new approach for the treatment of DR.

Entities:  

Keywords:  Amadori-glycated albumin; Diabetic retinopathy; MALAT1; Microglia; miR-124

Mesh:

Substances:

Year:  2018        PMID: 30151700     DOI: 10.1007/s00011-018-1184-1

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  46 in total

1.  Increases of vitreous monocyte chemotactic protein 1 and interleukin 8 levels in patients with concurrent hypertension and diabetic retinopathy.

Authors:  Yoshihiro Wakabayashi; Yoshihiko Usui; Yoko Okunuki; Takeshi Kezuka; Masaru Takeuchi; Takuya Iwasaki; Atsushi Ohno; Hiroshi Goto
Journal:  Retina       Date:  2011-10       Impact factor: 4.256

2.  The long noncoding RNA MALAT1 regulates the lipopolysaccharide-induced inflammatory response through its interaction with NF-κB.

Authors:  Gui Zhao; Zhenyi Su; Dan Song; Yimin Mao; Xiaohua Mao
Journal:  FEBS Lett       Date:  2016-08-04       Impact factor: 4.124

3.  Upregulation of retinal neuronal MCP-1 in the rodent model of diabetic retinopathy and its function in vitro.

Authors:  Ning Dong; Xiaoxin Li; Lin Xiao; Wenzen Yu; Bingsong Wang; Liqun Chu
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-09       Impact factor: 4.799

4.  Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy.

Authors:  J Kyle Krady; Anirban Basu; Colleen M Allen; Yuping Xu; Kathryn F LaNoue; Thomas W Gardner; Steven W Levison
Journal:  Diabetes       Date:  2005-05       Impact factor: 9.461

Review 5.  Diabetic retinopathy: recent advances towards understanding neurodegeneration and vision loss.

Authors:  Alistair J Barber
Journal:  Sci China Life Sci       Date:  2015-05-08       Impact factor: 6.038

6.  Microglial chemotactic signaling factors in Alzheimer's disease.

Authors:  James G McLarnon
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

7.  Baicalein Inhibits Amadori-Glycated Albumin-Induced MCP-1 Expression in Retinal Ganglion Cells via a MicroRNA-124-Dependent Mechanism.

Authors:  Ning Dong; Bing Xu; Hong Shi; Xin Tang
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

8.  Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy.

Authors:  Sampathkumar Rangasamy; Paul G McGuire; Carolina Franco Nitta; Finny Monickaraj; Sreenivasa R Oruganti; Arup Das
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

9.  Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p.

Authors:  M-Z Ma; B-F Chu; Y Zhang; M-Z Weng; Y-Y Qin; W Gong; Z-W Quan
Journal:  Cell Death Dis       Date:  2015-01-08       Impact factor: 8.469

10.  Retinal neuronal MCP-1 induced by AGEs stimulates TNF-α expression in rat microglia via p38, ERK, and NF-κB pathways.

Authors:  Ning Dong; Libin Chang; Bingsong Wang; Liqun Chu
Journal:  Mol Vis       Date:  2014-05-02       Impact factor: 2.367

View more
  4 in total

1.  Long Noncoding RNA NEAT1 Regulates TGF-β2-Induced Epithelial-Mesenchymal Transition of Lens Epithelial Cells through the miR-34a/Snail1 and miR-204/Zeb1 Pathways.

Authors:  Ning Dong
Journal:  Biomed Res Int       Date:  2020-05-31       Impact factor: 3.411

Review 2.  Long Noncoding RNAs and Mitochondrial Homeostasis in the Development of Diabetic Retinopathy.

Authors:  Renu A Kowluru
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-06       Impact factor: 6.055

Review 3.  Role of Long Non-Coding RNAs and the Molecular Mechanisms Involved in Insulin Resistance.

Authors:  Vianet Argelia Tello-Flores; Fredy Omar Beltrán-Anaya; Marco Antonio Ramírez-Vargas; Brenda Ely Esteban-Casales; Napoleón Navarro-Tito; Luz Del Carmen Alarcón-Romero; Carlos Aldair Luciano-Villa; Mónica Ramírez; Óscar Del Moral-Hernández; Eugenia Flores-Alfaro
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

4.  Nuclear Genome-Encoded Long Noncoding RNAs and Mitochondrial Damage in Diabetic Retinopathy.

Authors:  Ghulam Mohammad; Renu A Kowluru
Journal:  Cells       Date:  2021-11-23       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.